These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7673772)

  • 41. Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures.
    Devinsky O; Faught RE; Wilder BJ; Kanner AM; Kamin M; Kramer LD; Rosenberg A
    Epilepsy Res; 1995 Mar; 20(3):241-6. PubMed ID: 7796796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electromyographically Guided Nerve Combing Makes Microvascular Decompression More Successful in Hemifacial Spasm with Persistent Abnormal Muscle Response.
    Zhang X; Zhao H; Zhu J; Tang YD; Ying TT; Yuan Y; Li ST
    World Neurosurg; 2017 Jun; 102():85-90. PubMed ID: 28254601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nervus Intermedius Section to Mobilize the Anterior Inferior Cerebellar Artery in Microvascular Decompression Surgery for Hemifacial Spasm: A Technical Case Report.
    Yamamoto Y; Hashikata H; Toda H; Iwasaki K
    World Neurosurg; 2019 Feb; 122():491-494. PubMed ID: 30476669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
    Steinhoff BJ
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microvascular decompression for hemifacial spasm.
    Barker FG; Jannetta PJ; Bissonette DJ; Shields PT; Larkins MV; Jho HD
    J Neurosurg; 1995 Feb; 82(2):201-10. PubMed ID: 7815147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of partial seizures and seizure-like activity with felbamate in six dogs.
    Ruehlmann D; Podell M; March P
    J Small Anim Pract; 2001 Aug; 42(8):403-8. PubMed ID: 11518421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemifacial spasm: results of microvascular decompression of the facial nerve in 54 patients.
    Auger RG; Piepgras DG; Laws ER
    Mayo Clin Proc; 1986 Aug; 61(8):640-4. PubMed ID: 3724243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Felbamate for partial seizures: results of a controlled clinical trial.
    Leppik IE; Dreifuss FE; Pledger GW; Graves NM; Santilli N; Drury I; Tsay JY; Jacobs MP; Bertram E; Cereghino JJ
    Neurology; 1991 Nov; 41(11):1785-9. PubMed ID: 1944909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxic epidermal necrolysis after initiation of felbamate therapy.
    Travaglini MT; Morrison RC; Ackerman BH; Haith LR; Patton ML
    Pharmacotherapy; 1995; 15(2):260-4. PubMed ID: 7624275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of felbamate in therapy for partial epilepsy in children.
    Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA
    J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of a new waveform for intraoperative monitoring of hemifacial spasms.
    Zheng X; Hong W; Tang Y; Ying T; Wu Z; Shang M; Feng B; Zhang W; Hua X; Zhong J; Li S
    Acta Neurochir (Wien); 2012 May; 154(5):799-805. PubMed ID: 22354720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Felbamate as an add-on therapy for refractory epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008295. PubMed ID: 21249704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intra-operative monitoring of two facial muscles in hemifacial spasm surgery.
    Hale T; Hoffman SN; Dehdashti AR
    Neurochirurgie; 2015 Aug; 61(4):266-70. PubMed ID: 26073921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin-A for the treatment of hemifacial spasm.
    Cuevas C; Madrazo I; Magallón E; Zamorano C; Neri G; Reyes E
    Arch Med Res; 1995; 26(4):405-8. PubMed ID: 8555735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Felbamate in the treatment of partial-onset seizures.
    Bourgeois BF
    Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics of felbamate in children.
    Kelley MT; Walson PD; Cox S; Dusci LJ
    Ther Drug Monit; 1997 Feb; 19(1):29-36. PubMed ID: 9029743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of intraoperative findings and postoperative outcomes between atypical and typical hemifacial spasms.
    Liu M; Xia L; Zhong J; Li B; Dou N; Li S
    Neurosurg Rev; 2018 Apr; 41(2):593-597. PubMed ID: 28831592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
    Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.